These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19638154)

  • 1. Transfusion medicine illustrated: Intrauterine transfusion for homozygous alpha(0) thalassemia reverses hydrops fetalis.
    Wang C; Ryan G
    Transfusion; 2009 Jun; 49(6):1043-4. PubMed ID: 19638154
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous alpha-thalassemia associated with hypospadias in three survivors.
    Fung TY; Kin LT; Kong LC; Keung LC
    Am J Med Genet; 1999 Jan; 82(3):225-7. PubMed ID: 10215545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero exchange transfusion in homozygous alpha-thalassaemia: a case report.
    Fung TY; Lau TK; Tam WH; Li CK
    Prenat Diagn; 1998 Aug; 18(8):838-41. PubMed ID: 9742574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal growth and development following in utero diagnosis and treatment of homozygous alpha-thalassaemia.
    Sohan K; Billington M; Pamphilon D; Goulden N; Kyle P
    BJOG; 2002 Nov; 109(11):1308-10. PubMed ID: 12452474
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-thalassemia major: antenatal diagnosis and management.
    Rubin LP
    Med Health R I; 2001 May; 84(5):152-5. PubMed ID: 11392952
    [No Abstract]   [Full Text] [Related]  

  • 6. Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation.
    Thornley I; Lehmann L; Ferguson WS; Davis I; Forman EN; Guinan EC
    Bone Marrow Transplant; 2003 Aug; 32(3):341-2. PubMed ID: 12858209
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydrops fetalis associated with homozygosity for hemoglobin Taybe (alpha 38/39 THR deletion) in newborn triplets.
    Arnon S; Tamary H; Dgany O; Litmanovitz I; Regev R; Bauer S; Dolfin T; Yacobovich J; Wolach B; Jaber L
    Am J Hematol; 2004 Jul; 76(3):263-6. PubMed ID: 15224363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine therapy for homozygous alpha-thalassemia.
    Carr S; Rubin L; Dixon D; Star J; Dailey J
    Obstet Gynecol; 1995 May; 85(5 Pt 2):876-9. PubMed ID: 7724145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis.
    Glenn OA; Bianco K; Barkovich AJ; Callen PW; Parer JT
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):769-72. PubMed ID: 17763280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation.
    Yi JS; Moertel CL; Baker KS
    J Pediatr; 2009 May; 154(5):766-8. PubMed ID: 19364562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review.
    Joshi DD; Nickerson HJ; McManus MJ
    Clin Med Res; 2004 Nov; 2(4):228-32. PubMed ID: 15931362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous alpha-thalassemia in a growth retarded, non-hydropic premature newborn.
    Ng YP; Joseph R; Biswas A
    J Perinatol; 2008 Feb; 28(2):158-9. PubMed ID: 18235510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
    Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
    Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha thalassemia major--new mutations, intrauterine management, and outcomes.
    Vichinsky EP
    Hematology Am Soc Hematol Educ Program; 2009; ():35-41. PubMed ID: 20008180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-immune hydrops fetalis successfully treated by intrauterine transfusion].
    Pál A; Vajda G
    Orv Hetil; 1994 May; 135(21):1147-8. PubMed ID: 8190499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection.
    Soothill P
    Lancet; 1990 Jul; 336(8707):121-2. PubMed ID: 1975307
    [No Abstract]   [Full Text] [Related]  

  • 17. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis.
    Ogburn PL; Ramin KD; Danilenko-Dixon D; Fairbanks VF; Ramsey PS
    Am J Obstet Gynecol; 2001 Jul; 185(1):238-9. PubMed ID: 11483935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity for the Mediterranean a-thalassemic deletion (hemoglobin Barts hydrops fetalis).
    Al-Allawi NA; Shamdeen MY; Rasheed NS
    Ann Saudi Med; 2010; 30(2):153-5. PubMed ID: 20220267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful in utero treatment of parvovirus B19-induced fetal hydrops in a case of twin pregnancy.
    Graesslin O; Andreoletti L; Dedecker F; Grolier F; Quereux C; Gabriel R
    Prenat Diagn; 2005 Apr; 25(4):336-7. PubMed ID: 15849786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.